EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic profiling of plasma reveals potential biomarkers for screening and early diagnosis of gastric cancer and precancerous stages

Lijing Du, Shasha Li, Xue Xiao, Jin Li, Yuanfang Sun, Shuai Ji, Huizi Jin, Zhaolai Hua, Juming Ma, Xi Wang, Shikai Yan

MedComm – Oncology · 2023-06 · 2 (2)

DOI: 10.1002/mog2.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Oncology, online erschienen am 23.05.2023. Verfasst von Lijing Du und 10 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) faces a great challenge in clinical diagnosis, that it often is detected at advanced stages and there is a loss of optimum time for treatment. Thus, it is necessary to develop effective strategies for diagnosis of GC. In this study, 82 participants were enrolled, including 50 chronic superficial gastritis (CSG) patients, 7 early gastric cancer (EGC), and 25 advanced gastric cancer (AGC) ones. Metabolites profiling on patient plasma was performed. Furthermore, the proposed biomarkers were used to create random forest models, in which discrimination efficiency and accuracy were ascertained by receiver operating characteristic (ROC) curve analysis. l ‐carnitine, l ‐proline, pyruvaldehyde, phosphatidylcholines (PC) (14:0/18:0), lysophosphatidylcholine (14:0) (LysoPC 14:0), lysinoalanine were defined as the potential biomarker panel for the diagnosis among CSG and EGC patients. Compared with EGC patients, PC(O‐18:0/0:0) and LysoPC(20:4(5Z,8Z,11Z,14Z)) were found to be upregulated in AGC patients, whereas l ‐proline, l ‐valine, adrenic acid, and pyruvaldehyde downregulated. Pathway analysis revealed several metabolism disorders, involving amino acids and lipid metabolism. ROC analysis demonstrated a high diagnostic performance in disease diagnosis between CSG and GC. The above results indicate that the biomarker panels are sensitive to early diagnosis of GC disease, which is expected to be a promising diagnostic tool for disease stratification studies.

Zitieren

APA

Du, L., Li, S., Xiao, X., Li, J., Sun, Y., Ji, S., Jin, H., Hua, Z., Ma, J., Wang, X., & Yan, S. (2023). Metabolomic profiling of plasma reveals potential biomarkers for screening and early diagnosis of gastric cancer and precancerous stages. MedComm – Oncology, 2(2). https://doi.org/10.1002/mog2.32

Vancouver

Du L, Li S, Xiao X, Li J, Sun Y, Ji S, et al. Metabolomic profiling of plasma reveals potential biomarkers for screening and early diagnosis of gastric cancer and precancerous stages. MedComm – Oncology. 2023;2(2). doi:10.1002/mog2.32

BibTeX
@article{Du2023,
  author = {Du, Lijing and Li, Shasha and Xiao, Xue and Li, Jin and Sun, Yuanfang and Ji, Shuai and Jin, Huizi and Hua, Zhaolai and Ma, Juming and Wang, Xi and Yan, Shikai},
  title = {Metabolomic profiling of plasma reveals potential biomarkers for screening and early diagnosis of gastric cancer and precancerous stages},
  journal = {MedComm – Oncology},
  year = {2023},
  volume = {2},
  number = {2},
  doi = {10.1002/mog2.32}
}
Kostenlos starten →